FirstCash Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that FirstCash Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.66B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $3.39B | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $3.15B | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $2.73B | Feb 3, 2025 |
| FY2023 | Dec 31, 2021 | $1.70B | Feb 5, 2024 |
| FY2020 | Dec 31, 2020 | $392.16M | Feb 1, 2021 |
| FY2020 | Sep 30, 2020 | $359.89M | Feb 1, 2021 |
| FY2020 | Jun 30, 2020 | $412.75M | Feb 1, 2021 |
| FY2020 | Mar 31, 2020 | $466.49M | Feb 1, 2021 |
| FY2020 | Dec 31, 2019 | $498.36M | Feb 1, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.67B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.51B | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $1.38B | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $1.26B | Feb 3, 2025 |
| FY2023 | Dec 31, 2021 | $1.13B | Feb 5, 2024 |
| FY2022 | Dec 31, 2020 | $1.08B | Feb 6, 2023 |
| FY2021 | Dec 31, 2019 | $1.18B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $1.09B | Feb 1, 2021 |
| FY2019 | Dec 31, 2017 | $1.05B | Feb 3, 2020 |
| FY2018 | Dec 31, 2016 | $669.13M | Feb 5, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.84B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.63B | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $1.51B | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $1.26B | Feb 3, 2025 |
| FY2023 | Dec 31, 2021 | $919.15M | Feb 5, 2024 |
| FY2020 | Dec 31, 2020 | $225.99M | Feb 1, 2021 |
| FY2020 | Sep 30, 2020 | $202.74M | Feb 1, 2021 |
| FY2020 | Jun 30, 2020 | $223.10M | Feb 1, 2021 |
| FY2020 | Mar 31, 2020 | $259.31M | Feb 1, 2021 |
| FY2020 | Dec 31, 2019 | $267.26M | Feb 1, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $330.38M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $258.82M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $219.30M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $253.50M | Feb 3, 2025 |
| FY2023 | Dec 31, 2021 | $124.91M | Feb 5, 2024 |
| FY2020 | Dec 31, 2020 | $32.73M | Feb 1, 2021 |
| FY2020 | Sep 30, 2020 | $15.06M | Feb 1, 2021 |
| FY2020 | Jun 30, 2020 | $25.87M | Feb 1, 2021 |
| FY2020 | Mar 31, 2020 | $32.92M | Feb 1, 2021 |
| FY2020 | Dec 31, 2019 | $54.15M | Feb 1, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $585.94M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $539.96M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $416.14M | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $469.31M | Feb 3, 2025 |
| FY2023 | Dec 31, 2021 | $223.30M | Feb 5, 2024 |
| FY2022 | Dec 31, 2020 | $222.26M | Feb 6, 2023 |
| FY2021 | Dec 31, 2019 | $231.60M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $243.43M | Feb 1, 2021 |
| FY2019 | Dec 31, 2017 | $220.36M | Feb 3, 2020 |
| FY2018 | Dec 31, 2016 | $96.85M | Feb 5, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.30B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $4.48B | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $4.29B | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $3.90B | Feb 3, 2025 |
| FY2023 | Dec 31, 2021 | $3.84B | Feb 5, 2024 |
| FY2022 | Dec 31, 2020 | $2.37B | Feb 6, 2023 |
| FY2021 | Dec 31, 2019 | $2.44B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $2.11B | Feb 1, 2021 |
| FY2019 | Dec 31, 2017 | $2.06B | Feb 3, 2020 |
| FY2018 | Dec 31, 2016 | $2.15B | Feb 5, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.02B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $2.42B | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $2.29B | Feb 3, 2025 |
| FY2023 | Dec 31, 2022 | $2.03B | Feb 5, 2024 |
| FY2022 | Dec 31, 2021 | $2.03B | Feb 6, 2023 |
| FY2021 | Dec 31, 2020 | $1.09B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $1.09B | Feb 1, 2021 |
| FY2019 | Dec 31, 2018 | $789.87M | Feb 3, 2020 |
| FY2018 | Dec 31, 2017 | $587.45M | Feb 5, 2019 |
| FY2017 | Dec 31, 2016 | $695.22M | Feb 20, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.28B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $2.05B | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $2.00B | Feb 3, 2025 |
| FY2023 | Dec 31, 2022 | $1.88B | Feb 5, 2024 |
| FY2022 | Dec 31, 2021 | $1.81B | Feb 6, 2023 |
| FY2021 | Dec 31, 2020 | $1.28B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $1.35B | Feb 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.32B | Feb 3, 2020 |
| FY2018 | Dec 31, 2017 | $1.48B | Feb 5, 2019 |
| FY2017 | Dec 31, 2016 | $1.45B | Feb 20, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.02B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.79B | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $1.73B | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $1.58B | Feb 3, 2025 |
| FY2023 | Dec 31, 2021 | $1.54B | Feb 5, 2024 |
| FY2022 | Dec 31, 2020 | $977.38M | Feb 6, 2023 |
| FY2021 | Dec 31, 2019 | $948.64M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $917.42M | Feb 1, 2021 |
| FY2019 | Dec 31, 2017 | $831.15M | Feb 3, 2020 |
| FY2018 | Dec 31, 2016 | $831.15M | Feb 5, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.67B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.41B | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $1.22B | Feb 3, 2025 |
| FY2023 | Dec 31, 2022 | $1.06B | Feb 5, 2024 |
| FY2022 | Dec 31, 2021 | $866.68M | Feb 6, 2023 |
| FY2021 | Dec 31, 2020 | $789.30M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $727.48M | Feb 1, 2021 |
| FY2019 | Dec 31, 2018 | $606.81M | Feb 3, 2020 |
| FY2018 | Dec 31, 2017 | $494.46M | Feb 5, 2019 |
| FY2017 | Dec 31, 2016 | $387.40M | Feb 20, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $125.20M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $175.10M | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $127.02M | Feb 3, 2025 |
| FY2023 | Dec 31, 2022 | $117.33M | Feb 5, 2024 |
| FY2022 | Dec 31, 2021 | $120.05M | Feb 6, 2023 |
| FY2021 | Dec 31, 2020 | $65.85M | Feb 28, 2022 |
| FY2021 | Dec 31, 2019 | $46.53M | Feb 28, 2022 |
| FY2021 | Dec 31, 2018 | $71.79M | Feb 28, 2022 |
| FY2020 | Dec 31, 2017 | $114.42M | Feb 1, 2021 |
| FY2019 | Dec 31, 2016 | $89.96M | Feb 3, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.22B | Feb 9, 2026 |
| FY2024 | Dec 31, 2024 | $1.75B | Feb 3, 2025 |
| FY2023 | Dec 31, 2023 | $1.62B | Feb 5, 2024 |
| FY2022 | Dec 31, 2022 | $1.39B | Feb 6, 2023 |
| FY2021 | Dec 31, 2021 | $1.31B | Feb 28, 2022 |
| FY2020 | Dec 31, 2020 | $623.00M | Feb 1, 2021 |
| FY2019 | Dec 31, 2019 | $635.00M | Feb 3, 2020 |
| FY2018 | Dec 31, 2018 | $595.00M | Feb 5, 2019 |
| FY2017 | Dec 31, 2017 | $407.00M | Feb 20, 2018 |
| FY2016 | Dec 31, 2016 | $460.00M | Mar 1, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7 | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | 5 | Feb 3, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 5, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 6, 2023 |
| FY2021 | Dec 31, 2019 | 3 | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | 3 | Feb 1, 2021 |
| FY2019 | Dec 31, 2017 | 3 | Feb 3, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Feb 5, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7 | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | 5 | Feb 3, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 5, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 1, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 1, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 1, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 1, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 1, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 43.98M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | 44.75M | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | 45.11M | Feb 3, 2025 |
| FY2023 | Dec 31, 2022 | 46.29M | Feb 5, 2024 |
| FY2022 | Dec 31, 2021 | 48.48M | Feb 6, 2023 |
| FY2021 | Dec 31, 2020 | 41.04M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | 42.33M | Feb 1, 2021 |
| FY2019 | Dec 31, 2018 | 43.60M | Feb 3, 2020 |
| FY2018 | Dec 31, 2017 | 46.91M | Feb 5, 2019 |
| FY2017 | Dec 31, 2016 | 48.51M | Feb 20, 2018 |